Answers are grounded in this paper and cite their sources.
Azido‐copper(II) and ‐copper(I) complexes of 1‐alkyl‐2‐[(o‐thioalkyl)phenylazo]imidazole (SRaaiNR′) have been prepared and studied. Complex 2 [Cu(SRaaiNR′)(μ1,1‐N3)(N3)]2 dimerises via end‐to‐end (μ1,3)‐N3 to form a tetrameric structure. Azido‐copper(I) complexes of the ligands are obtained as MeOH‐bridged dimers, [Cu(SRaaiNR′)(N3)(μ‐OHMe)]2 (3). The electronic spectra suggest that a small reorganisation energy (0.08 eV) is associated with the change in electronic configuration, structure and oxidation state from CuII to CuI. Redox interconversion, CuII ↔ CuI, [Cu(SMeaaiNMe)(μ‐N3)(N3)]2 (2a) ↔ [Cu(SMeaaiNMe)(N3)(μ‐OHCH3)]2 (3a), has been performed in one case. The tetranuclear complex shows ferromagnetic and antiferromagnetic interactions. The spectra, redox chemistry and magnetism are explained by DFT studies.
No takes yet. Share an insight, caveat, or question.
Bhunia et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: